The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals
Open accessAbstract
CONTEXT: Due to its good correlation to glycemic clamp, HOMA-IR has been widely utilized as insulin resistance index in clinical and epidemiological studies involving non-alcoholic fatty liver disease carriers. However, values used for this parameter have shown large variability. OBJECTIVE: To identify the HOMA-IR cut value that best distinguishes non-diabetic non-alcoholic fatty liver disease patients from a control group. METHODS: One hundred sixteen non-alcoholic fatty liver disease patients were studied, diagnosed by clinical, biochemical, and liver image or biopsy criteria, and 88 healthy individuals, without any liver disease and testing for oral glucose tolerance within normality. These groups did not differ in age and gender. All were submitted to oral glucose tolerance test and blood samples were collected for glucose and insulin measurements by immunofluorometric method. HOMA-IR was calculated according to the formula: fasting insulin (µU/L) x fasting glucose (nmol/L)/22.5. RESULTS: NAFLD patients showed higher insulin, glycemia, and HOMA-IR values than control group, even when excluding glucose intolerant and diabetes mellitus patients by their glycemic curves. HOMA-IR 75th percentile for control group was 1.78 and the best area under the curve index was obtained for HOMA-IR values of 2.0 [AUC= 0.840 (0.781-0.899 CI 95%), sensitivity (Se): 85%, specificity (Sp): 83%] while value 2.5 showed best specificity without important loss in sensitivity [AUC=0,831 (0.773-0.888) Se = 72%, Sp = 94%]. CONCLUSION: HOMA-IR values above or equal to 2.0 or 2.5 show enhanced diagnostic value in distinguishing non-alcoholic fatty liver disease carriers from control group individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous proposed scoring systems have identified persons with overweight or obesity at risk of SO [16, 33].”
From Sarcopenic Obesity Phenotype Index (SOP i ): A Population‐Based Study (2025) · cites this paper as [33]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 1×
“(19), shows significant correlation to glycemic clamp in non-diabetic patients and has been widely utilized in NAFLD clinical studies(2, 13, 14).”
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,255
Diagnosis and Classification of diabetes mellitus
Rossi, G. (2014) · Diapedia.org eBooks · doi:10.14496/dia..20 · Cited by 3,212
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,728
Chitturi, S., Abeygunasekera, S., Farrell, G. C., Holmes-Walker, J., Hui, J. M., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.30692 · Cited by 1,122
Etiopathogenesis of Nonalcoholic Steatohepatitis
Chitturi, S., & Farrell, G. C. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12927 · Cited by 658
Pathology of Nonalcoholic Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2007) · American Journal of Clinical Pathology · doi:10.1309/rtpm1py6ygbl2g2r · Cited by 469
Clinical Depression Versus Distress Among Patients With Type 2 Diabetes
Fisher, L., Skaff, M. M., Mullan, J. T., Arean, P., Mohr, D., Masharani, U., Glasgow, R., & Laurencin, G. (2007) · Diabetes Care · doi:10.2337/dc06-1614 · Cited by 465
Song, Y., Manson, J. E., Tinker, L. F., Howard, B. V., Kuller, L. H., Nathan, L., Rifai, N., & Liu, S. (2007) · Diabetes Care · doi:10.2337/dc07-0358 · Cited by 362
Yeckel, C. W., Weiss, R., Dziura, J., Taksali, S. E., Dufour, S., Burgert, T. S., Tamborlane, W. V., & Caprio, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031503 · Cited by 352
Non-alcoholic fatty liver disease and the metabolic syndrome: An update
Rector, R. S., Thyfault, J. P., Wei, Y., & Ibdah, J. A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.185 · Cited by 337
Pathogenesis and management issues for non-alcoholic fatty liver disease
Duvnjak, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i34.4539 · Cited by 266
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease
Angulo, P., Alba, L. M., Petrovic, L. M., Adams, L. A., Lindor, K. D., & Jensen, M. D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.020 · Cited by 198
Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome?
Musso, G., Gambino, R., Bo, S., Uberti, B., Biroli, G., Pagano, G., & Cassader, M. (2008) · Diabetes Care · doi:10.2337/dc07-1526 · Cited by 197
Shimada, M., Kawahara, H., Ozaki, K., Fukura, M., Yano, H., Tsuchishima, M., Tsutsumi, M., & Takase, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01322.x · Cited by 155
Lee, S., CHOI, S., Kim, H. J., Chung, Y., Lee, K. W., Lee, H. C., Huh, K. B., & Kim, D. J. (2006) · Journal of Korean Medical Science · doi:10.3346/jkms.2006.21.4.695 · Cited by 148
Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension
Lansang, M. C. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01229-2 · Cited by 115
Comparative evaluation of simple indices of insulin resistance
Vaccaro, O., Masulli, M., Cuomo, V., Rivellese, A. A., Uusitupa, M. I. J., Vessby, B. O., Hermansen, K., Tapsell, L. C., & Riccardi, G. (2004) · Metabolism · doi:10.1016/j.metabol.2004.05.017 · Cited by 66
Aller, R., de Luis, D. A., Fernández-Salazar, L. I., Calle, F., Velayos, B., Olcoz, J. L., Izaola, O., Sagrado, M. G., Conde, R., & González, J. M. D. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9981-3 · Cited by 65
Chalasani, N., Deeg, M. A., Persohn, S. A., & Crabb, D. W. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07619.x · Cited by 64
Patrick, L. (2002) · PubMed · Cited by 64
Duseja, A. K., Thumburu, K. K., Das, A., Dhiman, R. K., Chawla, Y. K., Bhadada, S. K., & Bhansali, A. K. (2007) · PubMed · Cited by 38
Leonetti, F., Iacobellis, G., Zappaterreno, A., Ribaudo, M. C., Tiberti, C., Vecci, E., & Mario, U. D. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80027-9 · Cited by 20
Perugini, R. A., Quarfordt, S. H., Baker, S. P., Czerniach, D. R., Litwin, D., & Kelly, J. J. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0158-3 · Cited by 17
HOMA test in diabetic patients with simultaneous pancreas and kidney transplantation
Aguilera, E., Recasens, M., Flores, L., Ricart, M. J., Casamitjana, R., Fernández‐Cruz, L., & Esmatjes, E. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(01)02831-7 · Cited by 8
Non-HDL-cholesterol, waist circumference and the HOMA index: Correlations in the healthy
Ybarra, J., Sánchez-Hernández, J., & Pérez, A. (2005) · Global Heart · doi:10.1016/j.precon.2005.05.002 · Cited by 5
Cited by
Sorted by citations
Critical review on the presence of phthalates in food and evidence of their biological impact
Giuliani, A., Zuccarini, M., Cichelli, A., Khan, H., & Reale, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17165655 · Cited by 420
Obesity subtypes, related biomarkers & heterogeneity
Mayoral, L. P.-C., Andrade, G. M., Mayoral, E. P.-C., Hernández‐Huerta, M. T., Canseco, S. P., Canales, F. J. R., Cabrera-Fuentes, H. A., Cruz, M. M., Pérez-Santiago, A. D., Alpuche, J. J., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1768_17 · Cited by 313
Sarcopenia and Sarcopenic Obesity and Mortality Among Older People
Benz, E., Pinel, A., Guillet, C., Capel, F., Pereira, B., De Antonio, M., Pouget, M., Cruz-Jentoft, A. J., Eglseer, D., Topinkova, E., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3604 · Cited by 261
Weight control and prevention of metabolic syndrome by green tea
Sae‐tan, S., Grove, K. A., & Lambert, J. D. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.12.013 · Cited by 178
Grace, A., Chan, E., Giallauria, F., Graham, P. L., & Smart, N. A. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0518-6 · Cited by 174
Metadata
- Authors
- Salgado, A. L. F. D. A., Carvalho, L. D., Oliveira, A. C., Santos, V. N. D., Vieira, J. G., & Parise, E. R.
- Affiliations
- Universidade Federal de São Paulo, Brazil
- Universidade Federal de São Paulo (BR)
- Venue
- Arquivos de Gastroenterologia
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2010-06
- Volume
- 47
- Issue
- 2
- Pages
- 165-169
- ISSN
- 0004-2803 (ISSN-L)
- OpenAlex
- W2156773567
- Cited by
- 315
- References
- 31
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 38 · 2023: 40 · 2022: 34 · 2021: 40 · 2020: 27 · 2019: 26 · 2018: 17 · 2017: 16 · 2016: 15 · 2015: 11 · 2014: 3 · 2013: 7 · 2012: 2
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Arquivos de Gastroenterologia (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- HOMA-IR, insulin resistance, non-alcoholic fatty liver disease, diagnostic thresholds, fasting insulin, fasting blood glucose, oral glucose tolerance test, diagnostic accuracy, non-diabetic patients
- MeSH terms
- Adult, Blood Glucose, Diagnosis, Differential, Fasting, Fatty Liver, Female, Homeostasis, Humans, Insulin Resistance, Male, Reference Values, Fluoroimmunoassay, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review